Form 4: ImmunityBio Director Simon Barry J. Simon Exercises Stock Options, Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Director Simon Barry J. Simon exercised stock options and disposed of shares of ImmunityBio, Inc. to cover tax obligations on February 22, 2025.
Summary
- On February 22, 2025, Simon Barry J. Simon, a director of ImmunityBio, Inc., exercised restricted stock units (RSUs) converting into 15,243 shares of common stock.
- Simultaneously, Simon disposed of 5,453 shares of common stock at a price of $3.42 to satisfy tax obligations related to the RSU vesting.
- Following these transactions, Simon directly owns 3,243,571 shares of ImmunityBio, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects a standard transaction related to stock options and tax obligations. It doesn't indicate any specific positive or negative outlook for the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Key Dates
| Date | Description |
|---|---|
| 02/22/2024 | Vesting commencement date for the RSU award. |
| 02/21/2025 | Closing price of ImmunityBio's common stock used to calculate shares withheld. |
| 02/22/2025 | Date of transaction: RSU exercise and share disposal. |
| 02/25/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.